Yazar "Yayla, Çağrı" için listeleme
-
New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study
Altay, Servet; Yıldırımtürk, Özlem; Çakmak, Hüseyin Altuğ; Aşkın, Lütfü; Sinan, Ümit Yaşar; Beşli, Feyzullah; Gedikli, Ömer; Tok, Özge Özden; Karadeniz, Fatma Özpamuk; Ünlü, Serkan; Yanık, Ahmet; Uçar, Fatih Mehmet; Duman, Hakan; Canpolat, Uğur; Koroğlu, Bayram; Yayla, Çağrı; Özcan, Kazım Serhan; Velibey, Yalçın; Gülel, Okan; Kalkan, Mehmet Emin; Karaca, Gürkan; Akboğa, Mehmet Kadri; Akdağ, Serkan; Eren, Mehmet; Şahin, Mahmut; Pehlivanoğlu, Seçkin (Turkish Soc Cardiology, 2017)Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). in this study, we aimed to evaluate ... -
Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry
Erol, Mustafa Kemal; Kayıkcıoğlu, Meral; Kılıçkap, Mustafa; Güler, Arda; Öztürk, Önder; Tuncay, Burcu; İnci, Sinan; Balaban, İsmail; Tatar, Fatih Paşa; Çırakoğlu, Ömer Faruk; Gazi, Emine; Bakırcı, Eftal Murat; Yayla, Çağrı; Astarcıoğlu, Mehmet Ali; Karaduman, Bilge Duran; Aksu, Ekrem; Alsancak, Yakup; Emlek, Nadir; Tigen, Mustafa Kürşat; Çağlar, Nihan Turan; Düz, Ramazan; İnanır, Mehmet; Özdoğan, Öner; Yavuzgil, Oğuz (AVES, 2021)Objective: In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial ...